Biologic Augmentation of Foot and Ankle Arthrodeses with an Allogeneic Cancellous Sponge.
Publication/Presentation Date
3-1-2014
Abstract
This case series was conducted to assess the safety and efficacy of using an allogeneic cancellous bone sponge for augmentation of foot and ankle arthrodeses. Twenty-five patients were prospectively enrolled in the study prior to undergoing fusion and were then followed for 12 months postoperatively. There were 45 joints: 7 ankles, 12 subtalars, 12 talonaviculars, 6 calcaneocuboids, 1 naviculocuneiform, 6 first tarsometatarsals, and 1 second tarsometatarsal. Patient-reported outcomes of pain (visual analog scale) and function (American Orthopaedic Foot and Ankle Society score) were obtained preoperatively and postoperatively at 6 and 12 months. No complications were noted intraoperatively or during the follow-up period. Three months postoperatively, radiographic osseous union was noted in 52% (13/25) of patients, which further increased to 96% (24/25) of patients at 6 and 12 months. There was no statistically significant difference in union time between joints [H(6)=11.5; P=.08]. Statistically significant improvements in pain (P≤.002) and function (P
Volume
37
Issue
3
First Page
230
Last Page
236
ISSN
1938-2367
Published In/Presented At
Protzman, N. M., Galli, M. M., Bleazey, S. T., & Brigido, S. A. (2014). Biologic augmentation of foot and ankle arthrodeses with an allogeneic cancellous sponge. Orthopedics, 37(3), e230-e236. doi:10.3928/01477447-20140225-54
Disciplines
Orthopedics | Other Medical Specialties | Surgery
PubMedID
24762149
Peer Reviewed for front end display
Peer-Reviewed
Department(s)
Department of Surgery
Document Type
Article